Table of Contents
Sun Pharma Business Overview
Sun Pharmaceutical is engaged in the business of manufacturing, developing, and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries have various manufacturing facilities spread across the world with trading and other incidental and related activities extending to the global market. It is the largest pharmaceutical company in India.
Sun Pharma Financial Performance
| FY 2022 | FY 2023 | FY 2024 | |
|---|---|---|---|
| Revenue | 38,654 | 43,886 | 48,497 |
| Expense | 28,397 | 32,235 | 35,479 |
| OPM (%) | 27% | 27% | 27% |
| Net income | 3,389 | 8,513 | 9,610 |
| EPS | 13.64 | 35.32 | 39.91 |
Sun Pharma Financial Ratios
| PE Ratio | ROCE | ROE | PEG Ratio |
| 42.0 | 17.3 % | 49.4 % | 1.79 |
| Book Value | ROA | Debt to equity | Piotroski score |
| ₹ 255 | 12.1 % | 0.05 | 9.00 |
Sun Pharma Peer comparison
| PE ratio | ROCE % | OPM % | |
|---|---|---|---|
| Sun Pharma | 41.95 | 17.32 | 27.03 |
| Cipla | 29.71 | 22.80 | 24.92 |
| Dr. Reddy’s Lab | 19.56 | 26.53 | 27.61 |
| Zydus | 25.53 | 22.34 | 28.93 |
Indian Stock market has grown over the last couple of decades. However, little has gone towards bolstering the participation of retail investors in the market. Through its unbiased approach of dissecting the prevalent challenges and finding ways for small investors to make money in the market, Stock Market Dekho aims to help individual investors along their stock market journey.
Disclaimer: No content on this website should be treated as investment advice. All the content offered on the website is for informational purposes only. Please contact your adviser before making an investment.
Contact Us:- admin@stockmarketdekho.in
Pages
Follow us
Proudly powered by WordPress
Pingback: Cipla Share Price
Pingback: Dr. Reddys Lab Share Price